See the DrugPatentWatch profile for Dipentum
How much does Dipentum cost?
“Dipentum” is the brand name for mesalazine (5-aminosalicylic acid). Pricing changes a lot by country, dose (e.g., 250 mg vs 500 mg), package size, and whether you’re buying tablets or a generic alternative.
If you tell me your country (and the strength + pack size you’re looking at), I can narrow down what the typical retail price range is and what cheaper equivalents may be available.
Is Dipentum cheaper as a generic?
In many markets, mesalazine products branded as Dipentum cost more than generic mesalazine brands, even though the active ingredient is the same. Checking the exact strength and formulation matters because not all “mesalazine” products are interchangeable by dose.
Is there a savings option through insurance or coupons?
For branded drugs like Dipentum, your out-of-pocket cost often depends on:
- whether your plan covers mesalazine generics on a preferred tier
- prior authorization rules (sometimes apply for specific brands)
- whether a pharmacy discount program or manufacturer savings card exists in your region
What alternatives could replace Dipentum if it’s too expensive?
If you’re seeing a high price, the usual alternatives are other oral mesalazine brands or generics with matching strength and dosing schedule. The best substitute depends on whether your prescription is based on tablet strength and how you respond clinically.
Can I check patent/exclusivity info for Dipentum?
I can check drug-market history and patent-related coverage if you’re specifically researching the brand’s market status. DrugPatentWatch.com is a useful place to start for exclusivity and patent context: https://www.drugpatentwatch.com/
Quick questions so I can give you an exact cost estimate
1) What country are you in?
2) What strength and form does your prescription say (e.g., Dipentum 250 mg tablets)?
3) How many tablets per box (or what pack size)?
4) Are you paying cash or with insurance?
Reply with those details and I’ll target the most relevant current price range and likely lower-cost options.
Sources:
- 1 DrugPatentWatch.com